efruxifermin
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for efruxifermin, covering 2022-08-04 to 2026-07-21. Get the full timeline:
Most recent: Clinical Trial Results: A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry) [Phase 2]